Drug Development

Lonza is revolutionizing drug development with its AI-driven route scouting technology, allowing pharmaceutical companies to fast-track their investigational new drug...

Despite their track record of demonstrating significant therapeutic efficacy, biologics still face daunting challenges in their drug delivery. Biologics such...

The pharmaceutical sector is still a hub for new patent developments. The development of novel treatment paradigms, the severity of...

The creation of a tool that can enable organic chemical processes that were not possible before has given the pharmaceutical...

Quick delivery of toxicological materials According to Alejandro Fernandez Martell and James Berrie from Lonza, a bottleneck has developed in...

The radiopharmaceutical industry is growing very quickly. In the past few years, there have been more mergers and acquisitions (M&A)...

The FDA has granted breakthrough status to an antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a...

Bayer and NextRNA Therapeutics, a biotechnology company, announced that they would be working together to create a new type of...

The capacity of a cell line to create a biologic that is both safe and stable in large numbers may...

The North American nuclear medicine market was estimated to be worth USD 2.05 billion in 2023 and is expected to...